Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 1–50 of 106 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04601584	GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL	terminated	Phase 1 / Phase 2	14	AO GENERIUMINDUSTRY	1	Sep 21, 2026	clinicaltrials
NCT06704152	BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS	terminated	Phase 1 / Phase 2	2	BlueSphere Bio, IncINDUSTRY	1	Sep 10, 2026	clinicaltrials